Cisplatin bioconjugated enzymatic GNPs amplify the effect of cisplatin with acquiescence.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
25 09 2019
Historique:
received: 11 01 2018
accepted: 29 03 2019
entrez: 27 9 2019
pubmed: 27 9 2019
medline: 30 10 2020
Statut: epublish

Résumé

Enzymatic gold nanoparticles (B-GNPs) have been synthesized using a natural anticancer agent bromelain (a cysteine protease) and these nanoparticles were used to bioconjugate Cisplatin (highly effective against osteosarcoma and lung cancer). Cisplatin bioconjugated bromelain encapsulated gold nanoparticles (B-C-GNPs) were found profoundly potent against same cancers at much lower concentration with minimum side effects due to the synergistic effect of bromelain. The B-C-GNPs have been observed to inhibit the proliferation of osteosarcoma cell lines Saos-2 and MG-63 with IC

Identifiants

pubmed: 31554850
doi: 10.1038/s41598-019-50215-y
pii: 10.1038/s41598-019-50215-y
pmc: PMC6761153
doi:

Substances chimiques

Reactive Oxygen Species 0
Gold 7440-57-5
Bromelains 9001-00-7
fruit bromelain EC 3.4.22.33
Cisplatin Q20Q21Q62J

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

13826

Références

Acc Chem Res. 2011 Oct 18;44(10):1050-60
pubmed: 21919457
Cancer Lett. 2007 Jun 8;250(2):194-205
pubmed: 17113707
J Biomol Struct Dyn. 1998 Apr;15(5):959-66
pubmed: 9619517
Eur J Cancer. 2011 Nov;47(16):2431-45
pubmed: 21703851
Am J Physiol Heart Circ Physiol. 2008 Mar;294(3):H1365-70
pubmed: 18192224
Cancer Res. 2003 Dec 15;63(24):8977-83
pubmed: 14695216
Angew Chem Int Ed Engl. 2005 Jan 14;44(4):520-54
pubmed: 15625667
Cancer Invest. 2001;19(3):292-315
pubmed: 11338887
J Am Chem Soc. 2007 May 23;129(20):6370-1
pubmed: 17465550
Hiroshima J Med Sci. 1975 Sep;24(2-3):185-93
pubmed: 780325
Bone. 2013 Aug;55(2):418-26
pubmed: 23571049
J Orthop Res. 2004 Jul;22(4):703-8
pubmed: 15183424
Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):15752-6
pubmed: 16239346
Cancer Treat Rev. 2006 Oct;32(6):423-36
pubmed: 16860938
Clin Immunol. 2002 Aug;104(2):183-90
pubmed: 12165279
J Colloid Interface Sci. 2011 Mar 15;355(2):402-9
pubmed: 21216410
Biomacromolecules. 2005 Jan-Feb;6(1):46-53
pubmed: 15638503
Sarcoma. 2012;2012:126906
pubmed: 23024593
J Clin Oncol. 1991 Oct;9(10):1766-75
pubmed: 1717666
J Am Chem Soc. 2007 Apr 25;129(16):5023-30
pubmed: 17402732
J Pharm Sci. 2008 Sep;97(9):3518-90
pubmed: 18200527
Cancer Res. 1995 Sep 1;55(17):3752-6
pubmed: 7641188
Colloids Surf B Biointerfaces. 2017 Dec 1;160:254-264
pubmed: 28942160
Technol Cancer Res Treat. 2013 Aug;12(4):275-84
pubmed: 23547973
J Am Chem Soc. 2009 Oct 21;131(41):14652-3
pubmed: 19778015
Cancer. 1990 Jun 1;65(11):2539-53
pubmed: 2337871
Cancer Res. 1994 Jul 1;54(13):3352-6
pubmed: 8012948
BMC Cancer. 2009 Nov 16;9:399
pubmed: 19917123
Colloids Surf B Biointerfaces. 2014 May 1;117:473-9
pubmed: 24368207
Anal Biochem. 1977 May 1;79(1-2):135-43
pubmed: 869171
J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:203-12
pubmed: 21199532
Ann Oncol. 2001 Nov;12(11):1619-30
pubmed: 11822764
Saudi J Biol Sci. 2015 Jan;22(1):42-9
pubmed: 25561882
J Am Chem Soc. 2007 Jul 11;129(27):8438-9
pubmed: 17569542
Cell. 2008 Jul 25;134(2):215-30
pubmed: 18662538
Chem Rev. 2004 Jan;104(1):293-346
pubmed: 14719978
Toxicol Appl Pharmacol. 2008 Jan 1;226(1):30-7
pubmed: 17889918
Cardiovasc Drugs Ther. 1998 Sep;12 Suppl 2:147-52
pubmed: 9794088
J Nanosci Nanotechnol. 2011 Feb;11(2):1632-5
pubmed: 21456254
Immunol Invest. 2008;37(4):263-77
pubmed: 18569070
Biochemistry. 1992 Jan 14;31(1):182-9
pubmed: 1310028
J Immunol. 1996 Nov 1;157(9):3980-7
pubmed: 8892631
Nat Biotechnol. 2008 Jan;26(1):83-90
pubmed: 18157119
J Agric Food Chem. 2006 Mar 22;54(6):2193-8
pubmed: 16536595
Int J Pharm. 2014 Jun 5;467(1-2):123-38
pubmed: 24680951
Adv Mater. 2009 Apr 20;21(31):3175-3180
pubmed: 20174478
Pharm Res. 2011 Feb;28(2):237-59
pubmed: 21104301
Cancer Res. 2010 Jan 15;70(2):440-6
pubmed: 20068163
Biochem J. 1994 May 15;300 ( Pt 1):107-10
pubmed: 8198520
Int J Mol Sci. 2016 Sep 13;17(9):
pubmed: 27649147
PLoS One. 2012;7(2):e31199
pubmed: 22319617
J Mol Biol. 1984 Oct 25;179(2):233-56
pubmed: 6502713
Bioconjug Chem. 2009 Dec;20(12):2247-53
pubmed: 19919059
Nano Lett. 2011 Jul 13;11(7):2938-43
pubmed: 21667930
J Am Chem Soc. 2009 Feb 18;131(6):2072-3
pubmed: 19170493
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Chem Soc Rev. 2008 Mar;37(3):479-89
pubmed: 18224258
Biomacromolecules. 2011 Jan 10;12(1):145-55
pubmed: 21128674
Biochim Biophys Acta. 1995 Apr 27;1248(2):123-8
pubmed: 7748893
EXCLI J. 2016 Dec 06;15:772-780
pubmed: 28337108
J Am Chem Soc. 2009 May 27;131(20):7079-85
pubmed: 19405534

Auteurs

Sana Iram (S)

Nanomedicine & Nanobiotechnology Lab, Department of Biosciences, Integral University, Lucknow, India.

Manaal Zahera (M)

Nanomedicine & Nanobiotechnology Lab, Department of Biosciences, Integral University, Lucknow, India.

Iram Wahid (I)

Nanomedicine & Nanobiotechnology Lab, Department of Biosciences, Integral University, Lucknow, India.

Abu Baker (A)

Nanomedicine & Nanobiotechnology Lab, Department of Biosciences, Integral University, Lucknow, India.

Mohammad Raish (M)

Department Pharmaceutics, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia.

Altaf Khan (A)

Department Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia.

Naushad Ali (N)

Quality Assurance Unit, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi Arabia.

Saheem Ahmad (S)

Nanomedicine & Nanobiotechnology Lab, Department of Biosciences, Integral University, Lucknow, India.

Mohd Sajid Khan (MS)

Nanomedicine & Nanobiotechnology Lab, Department of Biosciences, Integral University, Lucknow, India. research.sajid@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH